PFE

Pfizer Inc (PFE) is the lead sponsor of 200 active clinical trials listed on ClinicalTrials.gov^[5], including 55 Phase 3^[1], 49 Phase 2^[2], 54 Phase 1^[3], 6 Phase 4^[4].

Trial NCT04281485^[6] evaluates PF-06939926 in Duchenne Muscular Dystrophy with a target enrollment of 114 participants. Trial NCT03395197^[7] evaluates Talazoparib with enzalutamide in mCRPC with a target enrollment of 1054 participants. Trial NCT07029828^[8] evaluates Ritlecitinib higher dose in Severe Alopecia Areata with a target enrollment of 140 participants.

PFE has 8 Form 4 insider filings recorded at the SEC in the past 30 days^[9].